← Back to all trials
Recruiting
NCT05645809
Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery
Conditions: Laparoscopic Hysterectomy
Sex: Female
Ages: 19 Years – N/A
Phase: NA
Enrollment: 98
Sponsor: Samyang Biopharmaceuticals Corporation
Location: Korea, Republic of
Summary
Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture Compared to Quill MonodermTM Suture in Laparoscopic Surgery
Eligibility Criteria
Inclusion Criteria:1. Patients scheduled for hysterectomy by laparoscopic surgeryPatients who are scheduled to undergo hysterectomy after being diagnosed with benign tumors in the uterus, including uterine myoma, according to the medical judgment of the investigatorLaparoscopic surgery includes general laparoscopic surgery and robotic surgery.)Exclusion Criteria:Patients with contaminated woundsDiseases that may affect wound healingWhen gynecological malignancy or intra-abdominal metastasis is confirmed at the time of enrollment
Source: ClinicalTrials.gov (NCT05645809). StuddyBuddy aggregates publicly available trial information.